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Over the last decades, artificial intelligence (AI) has 
become more and more a part of our life, from personal 
to professional contexts. In the context of care, AI acts as 
a decision support tool which provides information not 
achievable by human ability alone [1–3]. Software based 
on machine learning, deep learning, or decision trees 
could analyze large amounts of patient data to identify 
patterns that lead to the identification of diagnosis or 
treatment. AI testing in a number of medical fields has led 
to impressive and encouraging results but its clinical val-
ue has still to be understood completely [4]. This requires 
not only to test AI effectiveness as a diagnostic support 
tool in healthcare context, but also to consider the pos-
sible consequences of its implementation in the clinical 
context.
For instance, while some healthcare professionals de-
clare a notable enthusiasm about the implementation of 
new technologies, using such tools in everyday clinical 
practice is another story. Health professionals should 
continually take important decisions affecting patients’ 
life or death as well as deal with patients’ sensitive situa-
tions involving complex emotions [5–7] and are also ex-
posed to an increasing risk of controversies and legal ac-
tions. Such risk may influence doctors’ attitude and their 
clinical practice [8–10] so that trusting a medical device 
to take decisions that could affect patients’ lives as well as 
one’s own career is no smooth process.
A crucial issue is that a typical AI software operates as 
a “black box” providing data without a detailed explana-
tion of the machine learning process that has led to results 
[11, 12]; also, despite the fact that AIs are becoming more 
and more able to analyze multiple and various kinds of 
data (e.g., natural language), health professionals could 
not be sure whether AIs are capable of detecting any kind 
of meaningful or confounding information (e.g., lying in 
consultation and clinical tests) [13]. On a practical note, 
we could not expect healthcare professionals to become 
experts in AI engineering and informatics. Yet, they de-
serve to be put in the condition of effortlessly using these 
devices, without worrying for mistakes [14]. One possible 
solution is XAI – or eXplainable Artificial Intelligence – a 
subdiscipline focused on teaching AIs how to explain 
their own outcomes and processes in an intelligible way 
to decision makers that are supposed to benefit from AIs’ 
assistance [11]. Relevant to this aim is the realization that 
XAI is not a technical issue but a problem for the social 
sciences [15, 16], because building useful explanations 
within AI capabilities requires understanding how hu-
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man professionals think and take decisions in the social 
context. In other words, the first option towards an evolu-
tion of technology is that AI becomes able to “talk human 
language” and adapt to the real-world contexts of use. Di-
versely, the alternative option consists in modifying users 
instead of the tool.
While participating in some conferences on AI and 
machine learning in healthcare, the authors of the present 
contribution noticed one specific reaction among some 
professionals (both engineers and doctors) regarding the 
trust and adoption issue, which could be summarized in 
one sentence: “Indeed everyday all of us use technologies 
we do not know how they work; it is normal. We just have 
to get used to them!” This is certainly true. Donald Nor-
man, famous psychologist, engineer, and among the 
founders of the Usability field, demonstrated that users 
form their own representation of how a given technology 
works [17] entirely based on the interface – the part of the 
technology they could actually see and interact with. 
Thus, users’ representation of technology has nothing to 
do with the designer or engineer’s representation, which 
takes into account hardware or technical functioning and 
basically corresponds to how the device actually works. 
Thus, to design technologies that are easy to use, one 
should not teach common users how technologies actu-
ally work; rather, it is important to design interfaces tak-
ing into account the way users naturally think and act. In 
any case, it is true that humans learn to use tools indepen-
dently of understanding how they actually work, and we 
could probably track back this attitude to the oldest tools, 
such as bow and arrow.
If it is natural to use technologies without under-
standing them, then trust and explanation are a problem 
for marketing and communication: enterprises design-
ing and selling AI should just exploit persuasion tech-
niques to reassure doctors about the reliability and trust-
worthiness of their products. Marketing psychology and 
captology (i.e., the discipline studying persuasion by 
technologies [18]) could give useful hints to this aim. 
For example, AI developers could (1) make AI devices 
and interfaces interesting, involving, and mildly chal-
lenging: a fluent and engaging interaction is pleasant per 
se, reducing critical thinking on the activity to be pur-
sued [19, 20]; (2) give AIs a positive visual appealing 
with nice and pleasant features, especially on the graph-
ics side: for example, personalization options and the 
inclusion of human-like virtual characters may improve 
trust and reduce risk of abandonment [21, 22]; (3) em-
ploy reputation and authority heuristic: it is known that 
people consistently rely on others to make decisions 
about trustworthiness or credibility of a source [23]; on 
this basis, having testimonials recognized as experts in 
the medical field would help AIs to be accepted by other 
professionals.
Marketing experts could certainly come up with addi-
tional useful strategies to promote AI usage, but is this 
really a solution? And if it is, is this the solution we should 
hope for?
Especially in the context of care, the usage of technolo-
gies without a detailed understanding of the machine 
learning process that leads to clinical outcomes can deter-
mine some obstacles to professional practice: (1) Employ-
ing the marketing strategy would promote a medical/
technological culture according to which the best tools 
are those you can use without asking questions; in other 
words, reducing doctors’ critical thinking on the resourc-
es they use on a daily basis. Secondarily, the promotion of 
a medical culture in which technologies can be used as 
“black boxes” can lead to overconfidence in doctors (i.e., 
relying on technology for tasks other than those it was 
originally designed to perform) and to deskilling (i.e., re-
ducing user’s abilities because activities can now be per-
formed by machines; [24, 25]). In such a scenario, doctors 
would not be able to intervene effectively when AI does 
not work or is under maintenance.
(2) Despite the fact that AI software uses a large amount 
of patient data to identify patterns that lead to the identi-
fication of diagnosis or treatment, errors may still be 
made (e.g., miscalculations, inaccuracies, misinterpreta-
tions, overestimations, underestimations…). Doctors 
who use AI despite the fact that they are “black boxes” 
could find themselves in severe difficulties in understand-
ing and justifying those errors and so, to defend them-
selves from possible legal actions or disciplinary mea-
sures.
(3) A limited understanding of how the AI arrived at 
conclusions (especially unexpected or counterintuitive 
ones) may result in healthcare professionals having a par-
tial understanding of the diagnosis as a whole, with en-
hanced difficulty to explain it to patients and caregivers 
in the context of a collaborative approach and shared de-
cision-making. In the long run, this could impact treat-
ment efficacy and also the credibility of the professional 
and of the entire healthcare organization involved.
Generally, we can say that using medical devices (AI 
or not) without having a clear understanding of their con-
tribution to practice means deceiving the patient, who 
trusts the medical expert and his or her professional 
choices. However, reducing trust to a matter of persua-
sion and communication-marketing would mean deceiv-
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ing both the doctor and the patient, because the former is 
not reminded of the importance of being in complete 
control of the diagnostic and therapeutic process.
Future research, development, and implementation of 
AI for medical practice should take into account the risks 
inherent in the choice outlined here. Despite the fact that 
developing AI able to explain its own processing (so, able 
to effectively collaborate with human doctors) is the hard 
way, it is also the option that points towards authentic 
empowerment of healthcare, because health profession-
als are then able to use their tools with awareness. Fur-
thermore, AI for healthcare development should not for-
get patients and caregivers, namely the ultimate bene-
fiters, so that AI too can be used not as a mere device but 
(through proper explanation in the collaborative deci-
sion-making) a tool for patient engagement in their own 
healthcare journey [26–28].
On the one hand, XAI researchers should probably 
give more and more importance to the real-life contexts 
of AI utilization, to design interface devices based on 
awareness of professionals’ knowledge, needs, and abil-
ities; on the other hand, the formation of future doctors 
should continue to cultivate health professionals’ criti-
cal thinking to face the risks of overconfidence and 
deskilling. In this scenario, as envisioned by recent trea-
tises on the topic [29, 30], it would be possible that AI 
becomes not only a resource to improve diagnosis and 
treatment identification, but a technology that helps 
doctors to recover the “time lost” in technical tasks. 
Such time could be given back to medical consultation, 
so as to improve active listening, shared decision-mak-
ing, and a truly patient-centered approach to medical 
practice.
Acknowledgements
This work was partially supported by the Italian Ministry of 
Health with Ricerca Corrente and 5x1000 funds for IEO European 
Institute of Oncology IRCCS. S.T. and G.P. were also supported by 
MIUR – Italian Ministry of University and Research (Departments 
of Excellence Italian Law n.232, 11th December 2016) for Univer-
sity of Milan. I.D. was supported by Fondazione Umberto Vero-
nesi.
Statement of Ethics
This contribution did not involve human or animal partici-
pants.
Disclosure Statement
The authors declare that they have no conflicts of interest.
Funding Sources
This contribution received no specific grant from any funding 
agency in the public, commercial, or not-for-profit sectors.
Author Contributions
All persons who meet authorship criteria are listed as authors. 
All authors attest that they have participated sufficiently in the 
work reported to take public responsibility for the material report-
ed. S.T. and I.D. prepared an initial draft of the manuscript. G.C. 
and G.P. supervised the process and contributed important intel-
lectual content to the ideas presented. All authors read, edited, and 
approved the final manuscript.
References
 1 Fazal MI, Patel ME, Tye J, Gupta Y. The past, 
present and future role of artificial intelli-
gence in imaging. Eur J Radiol. 2018 Aug; 105: 
246–50.
 2 Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, 
et al. Artificial intelligence in healthcare: past, 
present and future. Stroke Vasc Neurol. 2017 
Jun; 2(4): 230–43.
 3 Horgan D, Romao M, Morré SA, Kalra D. Ar-
ticifial interlligence: power for civilisation – 
and for better healthcare. Public Health 
Genomics. 2019. https://doi.org/10.1159/ 
000504785.
 4 Challen R, Denny J, Pitt M, Gompels L, Ed-
wards T, Tsaneva-Atanasova K. Artificial in-
telligence, bias and clinical safety. BMJ Qual 
Saf. 2019 Mar; 28(3): 231–7.
 5 Durosini I, Tarocchi A, Aschieri F. Therapeu-
tic Assessment with a Client with Persistent 
Complex Bereavement Disorder: A Single-
Case Time-Series Design. Clin Case Stud. 
2017; 16(4): 295–312.
 6 Arnaboldi P, Riva S, Crico C, Pravettoni G. A 
systematic literature review exploring the 
prevalence of post-traumatic stress disorder 
and the role played by stress and traumatic 
stress in breast cancer diagnosis and trajec-
tory. Breast Cancer (Dove Med Press). 2017 
Jul; 9: 473–85.
 7 Fioretti C, Mazzocco K, Pravettoni G. Psycho-
logical Support in Breast Cancer Patients: A 
Personalized Approach. In: Veronesi U, Gold-
hirsch A, Veronesi P, Gentilini O, Leonardi M, 
editors. Breast Cancer. New York: Springer 
International Publishing; 2017. pp. 841–7.
 8 Nahed BV, Babu MA, Smith TR, Heary RF. 
Malpractice liability and defensive medicine: 
a national survey of neurosurgeons. PLoS 
One. 2012; 7(6):e39237.
 9 Rothberg MB, Class J, Bishop TF, Friderici J, 
Kleppel R, Lindenauer PK. The cost of defen-
sive medicine on 3 hospital medicine services. 
JAMA Intern Med. 2014 Nov; 174(11): 1867–
8.
10 Sekhar MS, Vyas N. Defensive medicine: a 
bane to healthcare. Ann Med Health Sci Res. 
2013 Apr; 3(2): 295–6.
11 Adadi A, Berrada M: Peeking Inside the 
Black-Box: A Survey on Explainable Artificial 
Intelligence (XAI). IEEE Access 2018; 6: 
52138–52160.
12 Castelvecchi D. Can we open the black box of 
AI? Nature. 2016 Oct; 538(7623): 20–3.
Triberti/Durosini/Curigliano/PravettoniPublic Health Genomics4
DOI: 10.1159/000506014
13 Fantini F, Banis A, Dell’Acqua E, Durosini I, 
Aschieri F. Exploring Children’s Induced De-
fensiveness to the Tell Me a Story Test 
(TEMAS). J Pers Assess. 2017 May-Jun; 99(3): 
275–85.
14 Iannello P, Perucca V, Riva S, Antonietti A, 
Pravettoni G. What do physicians believe 
about the way decisions are made? A pilot 
study on metacognitive knowledge in the 
medical context. Eur J Psychol. 2015 Nov; 
11(4): 691–706.
15 Miller T. Explanation in artificial intelligence: 
insights from the social sciences. Artif Intell. 
2019; 267: 1–38.
16 Miller T, Hower P, Sonenberg L, Explainable 
AI. Beware of Inmates Running the Asylum. 
IJCAI (U S). 2017.
17 Norman DA. Some observations on mental 
models. In Mental Models 1983; 15-22.
18 Fogg BJ. Captology: The study of computers 
as persuasive technologies. In Conference on 
Human Factors in Computing Systems - Pro-
ceedings 1997.
19 Appel M, Richter T. Transportation and need 
for affect in narrative persuasion: A mediated 
moderation model. Media Psychol. 2010; 
13(2): 101–35.
20 Vanwesenbeeck I, Ponnet K, Walrave M. Go 
with the flow: how children’s persuasion 
knowledge is associated with their state of 
flow and emotions during advergame play. J 
Consum Behav. 2016; 15(1): 38–47.
21 Desmet P, Hekkert P. Framework of product 
experience. International journal of design, 
1(1)2007. National Science Council, Taipei, 
30-Apr-2007.
22 Triberti S, Chirico A, La Rocca G, Riva G. De-
veloping emotional design: emotions as cog-
nitive processes and their role in the design of 
interactive technologies. Front Psychol. 2017 
Oct; 8: 1773.
23 Metzger MJ, Flanagin AJ, Medders RB. Social 
and heuristic approaches to credibility evalu-
ation online. J Commun. 2010; 60(3): 413–39.
24 Lu J. Will Medical Technology Deskill Doc-
tors? Int Educ Stud. 2016; 9(7): 130–4.
25 Triki A, Weisner MM. Lessons from the lit-
erature on the theory of technology domi-
nance: possibilities for an extended research 
framework. J Emerg Technol Account. 2014; 
11(1): 41–69.
26 Graffigna G, Barello S, Triberti S. Patient En-
gagement: A consumer-centered model to in-
novate healthcare. Berlin: De Gruyter Open; 
2015. https://doi.
org/10.1515/9783110452440.
27 Aschieri F, De Saeger H, Durosini I. Thera-
peutic assessment and collaborative: empiri-
cal evidence. Prat Psychol. 2015; 21: 307–17.
28 Renzi C, Riva S, Masiero M, Pravettoni G. The 
choice dilemma in chronic hematological 
conditions: why choosing is not only a medi-
cal issue? A psycho-cognitive perspective. 
Crit Rev Oncol Hematol. 2016 Mar; 99: 134–
40.
29 Topol E. Deep Medicine. Basic Books; 2019.
30 Pravettoni G, Triberti S: Il Medico 4.0. EDRA, 
2019.
